SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
American Journal of Alzheimer's Disease and Other Dementias®
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sajan, F. D.
Right arrow Articles by Freedman, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sajan, F. D.
Right arrow Articles by Freedman, M. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Apoptotic Gene Expression in Alzheimer's Disease Hippocampal Tissue

Farrah D. Sajan, BS

Division of Geriatrics New York University School of Medicne, New York NY

Frank Martiniuk, PhD

Pulmonary Division New York University School of Medicine, New York, New York

David L. Marcus, PhD

Division of Geriatrics New York University School of Medicne, New York NY, david.marcus{at}med.nyu.edu

William H. Frey, II, PhD

Alzheimer's Disease Research Center, Health Partners Research Foundation at Regions Hospital St. Paul, Minnesota

Richard Hite, BS

Division of Geriatrics New York University School of Medicne, New York NY

Elizabeth Z. Bordayo, MS

Alzheimer's Disease Research Center, Health Partners Research Foundation at Regions Hospital St. Paul, Minnesota

Michael L. Freedman, MD

Division of Geriatrics New York University School of Medicne, New York NY

Alzheimer's disease (AD) is the major cause of dementia, accounting for 50% to 70% of the late-onset patients, with 17 to 20 million affected. It is characterized by neurofibrillary tangles, neuronal loss, and amyloid plaques in tissues of the cortex, hippocampus, and amygdala. Apoptosis or programmed cell death appears in the progression of AD. In this study, we investigated the gene expression of 14 apoptotic genes (E2F1, p21/WAF, ICE-LAP3, Fas Antigen, CPP-32, GADD153, ICE-ß, c-Fos, c-Jun, Bax-{alpha}, Bcl-2, Bcl-(x)L, BAK, and p53) in 5 normal and 6 AD human hippocampal tissues, using reverse transcription-polymerase chain reaction. Our results show an upregulation of gene expression in AD patients for c-Fos and BAK. ICE-ß, c-Jun, Bax-{alpha}, Bcl-x(L), p53, and GADD153 were found to be upregulated in some AD samples but were not detected or downregulated in other AD or normal samples. No gene expression was found for E2F1 , p21/WAF, ICE-LAP3, Fas Antigen, CPP32, or Bcl-2. These results indicate significant increases in c-Fos , c-Jun, and Bak; therefore, we suggest that these genes may be critical in the apoptotic cascades of AD.

Key Words: Alzheimer's disease • apoptosis • apoptotic gene expression • reverse transcription-polymerase chain reaction • human hippocampus

American Journal of Alzheimer's Disease and Other Dementias®, Vol. 22, No. 4, 319-328 (2007)
DOI: 10.1177/1533317507302447


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement